SIGN UP
LOG IN
News
XtalPi Holdings
--
--
0.00%
XTALPI AND PFIZER EXPAND STRATEGIC COLLABORATION TO ADVANCE AI-DRIVEN DRUG DISCOVERY AND MATERIALS SCIENCE SIMULATIONS
Reuters · 3h ago
Weekly Report: what happened at XtalPi Holdings last week (0623-0627)?
Weekly Report · 6h ago
Weekly Report: what happened at XtalPi Holdings last week (0616-0620)?
Weekly Report · 06/22 22:21
Weekly Report: what happened at XtalPi Holdings last week (0609-0613)?
Weekly Report · 06/15 22:22
XTALPI ANNOUNCES STRATEGIC ACQUISITION OF LIVERPOOL CHIROCHEM (LCC), UNLOCKING UNPRECEDENTED POWER IN CHEMICAL SPACE EXPLORATION
Reuters · 06/13 07:00
Weekly Report: what happened at XtalPi Holdings last week (0602-0606)?
Weekly Report · 06/08 22:22
Weekly Report: what happened at XtalPi Holdings last week (0526-0530)?
Weekly Report · 06/01 22:22
Weekly Report: what happened at XtalPi Holdings last week (0519-0523)?
Weekly Report · 05/25 22:22
Weekly Report: what happened at XtalPi Holdings last week (0512-0516)?
Weekly Report · 05/18 22:22
Weekly Report: what happened at XtalPi Holdings last week (0505-0509)?
Weekly Report · 05/11 22:22
Weekly Report: what happened at XtalPi Holdings last week (0428-0502)?
Weekly Report · 05/04 22:22
Weekly Report: what happened at XtalPi Holdings last week (0421-0425)?
Weekly Report · 04/27 22:23
Weekly Report: what happened at XtalPi Holdings last week (0414-0418)?
Weekly Report · 04/20 22:23
Weekly Report: what happened at XtalPi Holdings last week (0407-0411)?
Weekly Report · 04/13 22:23
XtalPi Holdings Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St · 04/11 23:43
Weekly Report: what happened at XtalPi Holdings last week (0331-0404)?
Weekly Report · 04/06 22:21
Weekly Report: what happened at XtalPi Holdings last week (0324-0328)?
Weekly Report · 03/30 22:22
An Intrinsic Calculation For XtalPi Holdings Limited (HKG:2228) Suggests It's 24% Undervalued
Simply Wall St · 03/28 01:22
Weekly Report: what happened at XtalPi Holdings last week (0317-0321)?
Weekly Report · 03/23 22:23
Weekly Report: what happened at XtalPi Holdings last week (0310-0314)?
Weekly Report · 03/16 22:21
About XtalPi Holdings
XtalPi Holdings Ltd, formerly QuantumPharm Inc, is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. The drug discovery solutions business is engaged in providing modular standalone solutions to or collaborating with a diverse range of biotechnology and pharmaceutical companies and academic institutions for novel drug discovery endeavors. The intelligent automation solutions business is engaged in the provision of solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.
MoreRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.